Overview
Sharice Gerber is a Registered Nurse specialist and a Radiation Oncologist in Voorhees, New Jersey. Dr. Gerber has been practicing medicine for over 10 years. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Graduate Institution
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
900 Centennial Blvd Bldg 1, Voorhees, NJ 08043
Two Cooper Plaza, 400 Haddon Avenue, 1st Floor, Camden, NJ 08103
400 W Route 38, Lower Level 1, Moorestown, NJ 08057
715 Fellowship Rd, Suite C, Mount Laurel, NJ 08054
Abramson Cancer Center Penn Presbyterian
Keith Cengel is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Cengel is highly rated in 38 conditions, according to our data. His top areas of expertise are Mesothelioma, Lung Cancer, Metastatic Pleural Tumor, Small Cell Lung Cancer (SCLC), and Liver Embolization. Dr. Cengel is currently accepting new patients.
Radiation Oncology At Thomas Jefferson University Hospital
Wenyin Shi is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Shi is highly rated in 33 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Mycosis Fungoides, and Gamma Knife Radiosurgery. Dr. Shi is currently accepting new patients.
Penn Radiation Oncology Perelman-Concourse Level
Jeffrey Bradley is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Bradley is highly rated in 26 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Thymic Epithelial Tumor. Dr. Bradley is currently accepting new patients.
Frequently Asked Questions about Dr. Sharice Gerber
How do I make an appointment with Dr. Sharice Gerber?
You can book an appointment with Dr. Sharice Gerber by calling their office at 856-325-6660. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sharice Gerber a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sharice Gerber is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sharice Gerber specialize in?
While Dr. Sharice Gerber is a Registered Nurse, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Registered Nurse.
Does Dr. Sharice Gerber accept my insurance?
Dr. Sharice Gerber accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 856-325-6660 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Gerber isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.